Related Experiment Videos
Current concepts in pediatric liver transplant
1Liver Transplant Services, Children's Hospital Medical Center, University of Cincinnati, Ohio 45229, USA.
Insights
Liver transplantation offers improved survival for end-stage liver disease. Advances in techniques and post-transplant care, including antiviral strategies, are crucial for optimizing outcomes in liver transplant recipients.
Area of Science:
- Hepatology
- Transplant Surgery
- Pediatric Gastroenterology
Background:
- Orthotopic liver transplantation has dramatically improved survival for children with end-stage liver disease.
- Surgical advancements and immunosuppression have increased 1-year survival rates to nearly 90% and enhanced quality of life.
- Expanding donor pool through techniques like split-liver and living-donor transplantation addresses the growing waiting list.
Purpose of the Study:
- To review the advancements in liver transplantation, focusing on techniques to expand the donor pool.
- To highlight the challenges in the post-operative period, particularly infectious complications.
- To emphasize the importance of early detection and treatment of viral infections in young liver recipients.
Main Methods:
- Review of current literature on orthotopic liver transplantation techniques.
- Analysis of post-operative complications, with a focus on infectious diseases.
- Discussion of strategies for donor pool expansion and management of viral infections.
Main Results:
- Liver transplantation significantly improves survival and quality of life for pediatric patients.
- Reduced-size, split-liver, and living-donor transplantation are viable options to expand donor availability.
- Viral infections remain a significant cause of morbidity and mortality in the post-transplant phase.
Conclusions:
- Continuous innovation in surgical techniques and immunosuppression is vital for successful liver transplantation.
- Effective management of infectious complications, especially viral infections, is critical for long-term outcomes.
- Early detection and novel antiviral therapies are essential to reduce post-transplant complications and improve patient prognosis.
Abstract:
Orthotopic liver transplantation has significantly improved the survival rate of children with end-stage liver disease. Efforts to correct abnormalities existing prior to transplantation coupled with improved surgical techniques and immunosuppression have led to better quality of life and 1-year survival rates approaching 90% in many centers. Despite this success the expanding waiting list population of all ages has driven development of operative techniques to expand the donor pool. Building on the success of reduced-size transplantation, split-liver and living-donor transplantation are now suitable alternatives, especially when used in candidates with satisfactory clinical stability. In the post-operative period, infectious complications represent an important cause of morbidity and mortality. Although antimicrobial regimens are effective in the immediate post-operative phase, acquisition of viral infections represents a major concern particularly in the young liver recipient. Early detection and development of new anti-viral agents are likely to decrease occurrence of post-transplant proliferative disorders and optimize longterm transplantation outcome.